578 filings
Page 9 of 29
S-8
gjnoykfqk bxczemei
23 Aug 13
Registration of securities for employees
12:00am
8-K
rtmw73o49sm3nn
8 Aug 13
Second Quarter 2013 Financial Results
12:00am
8-K
405yb3plq3n0h
25 Jul 13
Departure of Directors or Certain Officers
12:00am
8-K
81xnnrpk9 70
23 Jul 13
PROCYSBI® Receives Positive Opinion for Orphan Drug Exclusivity From the EU Committee for Orphan Medicinal Products
12:00am
CT ORDER
ibp9p95txd7z7nbvp49
15 Jul 13
Confidential treatment order
12:00am
8-K
lf1r8jisgrc
5 Jul 13
Entry into a Material Definitive Agreement
12:00am
424B5
bkq 87kxkjt4
3 Jul 13
Prospectus supplement for primary offering
12:00am
8-K
tu04 cwu35f1o
2 Jul 13
Raptor Pharmaceutical's PROCYSBI™ Receives Positive Recommendation From CHMP
12:00am
8-K
33zutxcec c3sy
25 Jun 13
Raptor's PROCYSBI™ Receives U.S. Orphan Drug Exclusivity
12:00am
10-KT/A
6c0cndc dgd
19 Jun 13
Annual report (with FYE transition) (amended)
12:00am
DEFA14A
tlto7nzmqdtvf55t
10 Jun 13
Additional proxy soliciting materials
12:00am
8-K
byfb0y4k1s39 d2
24 May 13
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
ep5qqsi 86nv
9 May 13
Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results
12:00am
8-K
vsey68lhh3a1
1 May 13
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of
12:00am
8-K
ykc4md9xya4m
9 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
quj1vylnu9pj30 yzut
15 Mar 13
Results of Operations and Financial Condition
12:00am